Search Results

There are 10741 results for: content related to: Aldosterone Blockers (Mineralocorticoid Receptor Antagonism) and Potassium-Sparing Diuretics

  1. Targeting the aldosterone pathway in cardiovascular disease

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 1, February 2012, Pages: 135–145, Finn Gustafsson, Michel Azizi, Johann Bauersachs, Frederic Jaisser and Patrick Rossignol

    Version of Record online : 2 NOV 2011, DOI: 10.1111/j.1472-8206.2011.01004.x

  2. Eplerenone-Mediated Regression of Electrical Activation Delays and Myocardial Fibrosis in Heart Failure

    Journal of Cardiovascular Electrophysiology

    Volume 25, Issue 5, May 2014, Pages: 537–544, CHRISTINE TANAKA-ESPOSITO, SUBHA VARAHAN, DARWIN JEYARAJ, YUAN LU and BRUCE S. STAMBLER

    Version of Record online : 10 MAR 2014, DOI: 10.1111/jce.12379

  3. Eplerenone for hypertension

    Intervention Review

    The Cochrane Library

    Tina SC Tam, May HY Wu, Sarah C Masson, Matthew P Tsang, Sarah N Stabler, Angus Kinkade, Anthony Tung and Aaron M Tejani

    Published Online : 28 FEB 2017, DOI: 10.1002/14651858.CD008996.pub2

  4. You have full text access to this OnlineOpen article
    Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone

    ESC Heart Failure

    Volume 2, Issue 3, September 2015, Pages: 150–158, Daniela Fraccarollo, Paolo Galuppo, Jan-Thorben Sieweke, L. Christian Napp, Paul Grobbecker and Johann Bauersachs

    Version of Record online : 28 JUL 2015, DOI: 10.1002/ehf2.12053

  5. You have free access to this content
    Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure

    European Journal of Heart Failure

    Volume 16, Issue 2, February 2014, Pages: 143–150, Javaid Iqbal, Yasir Parviz, Bertram Pitt, John Newell-Price, Abdallah Al-Mohammad and Faiez Zannad

    Version of Record online : 14 DEC 2013, DOI: 10.1111/ejhf.31

  6. You have free access to this content
    Spironolactone is More Effective Than Eplerenone at Lowering Blood Pressure in Patients With Primary Aldosteronism

    The Journal of Clinical Hypertension

    Volume 13, Issue 8, August 2011, Pages: 629–631, Michael J. Bloch and Jan N. Basile

    Version of Record online : 14 JUL 2011, DOI: 10.1111/j.1751-7176.2011.00495.x

  7. You have free access to this content
    Add-On Use of Eplerenone Is Effective for Lowering Home and Ambulatory Blood Pressure in Drug-Resistant Hypertension

    The Journal of Clinical Hypertension

    Volume 18, Issue 12, December 2016, Pages: 1250–1257, Kazuo Eguchi, Tomoyuki Kabutoya, Satoshi Hoshide, Shizukiyo Ishikawa and Kazuomi Kario

    Version of Record online : 13 JUN 2016, DOI: 10.1111/jch.12860

  8. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor

    Clinical and Experimental Pharmacology and Physiology

    Volume 31, Issue 10, October 2004, Pages: 704–709, Fraser M Rogerson, Yizhou Yao, Brian J Smith and Peter J Fuller

    Version of Record online : 19 NOV 2004, DOI: 10.1111/j.1440-1681.2004.04079.x

  9. You have free access to this content
    A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone

    Clinical Cardiology

    Volume 31, Issue 4, April 2008, Pages: 153–158, Allan Struthers, Henry Krum and Gordon H. Williams

    Version of Record online : 10 APR 2008, DOI: 10.1002/clc.20324

  10. Pharmacokinetics of Eplerenone After Single and Multiple Dosing in Subjects With and Without Renal Impairment

    The Journal of Clinical Pharmacology

    Volume 45, Issue 7, July 2005, Pages: 810–821, Dr William R. Ravis, Ms Susan Reid, Dr Domenic A. Sica and Dr Dwain S. Tolbert

    Version of Record online : 25 MAR 2013, DOI: 10.1177/0091270005275894

  11. You have free access to this content
    Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease

    European Journal of Heart Failure

    Volume 18, Issue 1, January 2016, Pages: 28–37, Peter Bramlage, Stephanie L. Swift, Martin Thoenes, Joan Minguet, Carmen Ferrero and Roland E. Schmieder

    Version of Record online : 3 DEC 2015, DOI: 10.1002/ejhf.444

    Corrected by:

    ERRATUM: Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease

    Vol. 19, Issue 6, 811, Version of Record online: 6 JUN 2017

  12. You have free access to this content
    Treatment Considerations With Aldosterone Receptor Antagonists

    The Journal of Clinical Hypertension

    Volume 13, Issue 1, January 2011, Pages: 65–69, Domenic A. Sica and John M. Flack

    Version of Record online : 4 OCT 2010, DOI: 10.1111/j.1751-7176.2010.00377.x

  13. You have free access to this content
    Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances

    European Journal of Clinical Investigation

    Volume 42, Issue 10, October 2012, Pages: 1112–1120, Paolo Galuppo and Johann Bauersachs

    Version of Record online : 26 APR 2012, DOI: 10.1111/j.1365-2362.2012.02676.x

  14. You have free access to this content
    Eplerenone: A Selective Aldosterone Receptor Antagonist (SARA)

    Cardiovascular Drug Reviews

    Volume 19, Issue 3, September 2001, Pages: 185–200, John A. Delyani, Ricardo Rocha, Chyung S. Cook, Dwain S. Tolbert, Stuart Levin, Barbara Roniker, Diane L. Workman, Yuen-lung L. Sing and Brian Whelihan

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2001.tb00064.x

  15. You have free access to this content
    Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension

    The Journal of Clinical Hypertension

    Volume 19, Issue 7, July 2017, Pages: 669–676, Tatjana Kalizki, Bernhard M.W. Schmidt, Ulrike Raff, Annemarie Reinold, Thomas K. Schwarz, Markus P. Schneider, Roland E. Schmieder and Andreas Schneider

    Version of Record online : 17 FEB 2017, DOI: 10.1111/jch.12986

  16. Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2129–2138, Margarita Pizarro, Nancy Solís, Pablo Quintero, Francisco Barrera, Daniel Cabrera, Pamela Rojas-de Santiago, Juan P. Arab, Oslando Padilla, Juan C. Roa, Han Moshage, Alexander Wree, Eugenia Inzaugarat, Ariel E. Feldstein, Carlos E. Fardella, Rene Baudrand, Arnoldo Riquelme and Marco Arrese

    Version of Record online : 23 FEB 2015, DOI: 10.1111/liv.12794

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 36, Issue 2, 314, Version of Record online: 22 NOV 2015

  17. You have free access to this content
    Eplerenone: A Selective Aldosterone Blocker

    Cardiovascular Drug Reviews

    Volume 21, Issue 3, September 2003, Pages: 169–184, Charles T. Stier Jr.

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2003.tb00114.x

  18. Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 2, February 2012, Pages: 155–162, H. Takata, Y. Takeda, A. Zhu, Y. Cheng, T. Yoneda, M. Demura, K. Yagi, S. Karashima and M. Yamagishi

    Version of Record online : 3 NOV 2011, DOI: 10.1111/j.1463-1326.2011.01499.x

  19. You have free access to this content
    Aldosterone antagonists for preventing the progression of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Davide Bolignano, Suetonia C Palmer, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 29 APR 2014, DOI: 10.1002/14651858.CD007004.pub3

  20. You have free access to this content
    Steroidal Mineralocorticoid Receptor Antagonists: Synthesis and Biology

    ChemistrySelect

    Volume 2, Issue 1, January 10, 2017, Pages: 175–189, Dr. Christopher Yarnold, Dr. J. Marie Bainbridge, Helen S. Boehm, Dr. Mark Brewer, Dr. Stephen Courtney, Dr. Hervé Deboves, Dr. Raffaella Di Lucrezia, Dr. Paul Giles, Dr. Estelle Hamelin, Dr. Jörn Jungmann, Dr. Amedeo Leonardi, Dr. Mirco Meniconi, Dr. Carlo Riva, Dr. Andreas Scheel, Dr. Suganthan Selvaratnam, Dr. Sakthi Shanmugathasan, Dr. Giorgio Sironi, Dr. Paolo Tavecchia and David Willows

    Version of Record online : 9 JAN 2017, DOI: 10.1002/slct.201601744